FDA 510(k)

BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel

Numéro K : K214122 · 2022-07-28

Date de décision2022-07-28

Code produitPCI

Comité consultatifMI

DécisionSubstantially Equivalent

Résumé du dispositif

BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson and Company. It received FDA 510(k) clearance on 2022-07-28 under 510(k) number K214122. The device is classified under product code PCI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel?

BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel is a medical device that received FDA 510(k) clearance on 2022-07-28. The listed applicant is Becton, Dickinson and Company. The 510(k) number is K214122.

When did BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel receive FDA 510(k) clearance?

BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel received FDA 510(k) clearance on 2022-07-28, under 510(k) number K214122.

Who is the listed applicant for BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel?

The FDA 510(k) record lists Becton, Dickinson and Company as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel?

The FDA product code for BD MAX Enteric Bacterial Panel, BD MAX Extended Enteric Bacterial Panel is PCI.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant Becton, Dickinson and Company en tant que demandeur

K262163BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth K260128BD Preset™ and BD A-Line™ Arterial Blood Collection Syringes K252506BD Vacutainer® Safety-Lok™ Blood Collection Set; BD Vacutainer® Safety-Lok™ Blood Collection Set with Pre-Attached Holder K252378BD® MiniDraw™ Capillary Blood Collection System with BD® MiniDraw™ SST™ Capillary Blood Collection Tube K260184Onclarity™ Self-Collection Kit K252040BD Vacutainer® Plasma Separator Tubes (PST™), BD Vacutainer® Sodium Heparin Blood Collection Tubes

Voir tous les 102 dispositifs →

Dispositifs connexes (Code : PCI)

K250358BD Enteric Bacterial Panel for BD COR System, BD Enteric Bacterial Panel plus for BD COR System, and Enteric Bacterial Panel Diluent for BD COR SystemBecton, Dickinson and Company K173330PanNAT STEC TestMicronics, Inc.K163571Great Basin Stool Bacterial Pathogens PanelGreat Basin Scientific, Inc.

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.